EUS引导下胆囊引流与经乳头胆囊引流治疗急性胆囊炎的比较
本研究为单中心回顾性分析,比较2013年5月至2018年1月间78例急性胆囊炎非手术患者接受EUS引导下透壁胆囊引流(40例)与经乳头胆囊引流(38例)的结果。EUS组临床成功率显著高于经乳头组(95.0% vs 76.3%,调整OR 7.14,95%CI 1.32-38.52),复发胆囊炎率较低(2.6% vs 18.8%,P=0.023),但多因素回归后仅呈趋势。作者认为经乳头引流仍应考虑作为需要暂时措施或需ERCP患者的一线治疗。
要点
- EUS引导下胆囊引流临床成功率95.0%,显著高于经乳头引流的76.3%(调整OR 7.14,95%CI 1.32-38.52)。
- EUS组复发胆囊炎率2.6%,低于经乳头组的18.8%(P=0.023),但多因素回归后仅呈趋势。
- 技术成功率、再干预率、住院时间和总体不良事件率两组相似。
核心结论
- EUS引导下胆囊引流的临床成功率高于经乳头引流,可能伴有较低的胆囊炎复发率。
- 对于有手术指征但需要暂时措施或需因其他原因行ERCP的患者,经乳头引流应考虑作为一线治疗。
研究设计与样本
- 单中心、美国高容量内镜中心的回顾性分析,纳入2013年5月至2018年1月数据库中的急性胆囊炎非手术患者78例。
- EUS引导下透壁胆囊引流40例(使用电灼增强和非电灼增强的腔道对接金属支架),经乳头胆囊引流38例(放置7F×15-cm双猪尾塑料支架)。
主要发现
- 首次尝试EUS引导下引流的技术成功率为39/40(97.5%),经乳头引流为32/38(84.2%)(调整OR 9.83;95%CI 0.93-103.86)。
- EUS引导下引流的临床成功率为38/40(95.0%),经乳头引流为29/38(76.3%)(调整OR 7.14;95%CI 1.32-38.52)。
- 单变量分析中EUS组复发胆囊炎率为2.6%,经乳头组为18.8%(P=0.023),多因素回归模型中仅呈趋势。
- 随访时间、再干预率、住院时间和总体不良事件率两组相似。
临床怎么用
- 作者认为,对于有手术指征但需要暂时措施或需因其他原因行ERCP的患者,经乳头引流应考虑作为一线治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: There is an evolving role for EUS-guided transmural gallbladder (GB) drainage. Endoscopic transpapillary GB drainage is a well-established, nonoperative treatment for acute cholecystitis. We compared the outcomes of 78 cases of EUS-guided versus transpapillary GB drainage at a single, U.S.-based, high-volume endoscopy center. METHODS: This was a retrospective analysis performed from May 2013 to January 2018, identified from a database of nonoperative patients with acute cholecystitis. Both electrocautery-enhanced and nonelectrocautery-enhanced lumen-apposing metal stents were used. For transpapillary drainage, guidewire access was obtained and then a transpapillary 7F × 15-cm double-pigtail plastic stent was placed. RESULTS: In patients who had successful transpapillary or transmural drainage, demographics data were similar. Technical success was observed in 39 of 40 patients (97.5%) who underwent first attempt at EUS-guided drainage versus 32 of 38 patients (84.2%) for first-attempt transpapillary drainage (adjusted odds ratio, 9.83; 95% confidence interval, .93-103.86). Clinical success was significantly higher with EUS drainage in 38 of 40 patients (95.0%) versus transpapillary drainage in 29 of 38 patients (76.3%) (adjusted odds ratio, 7.14; 95% confidence interval, 1.32-38.52). Recurrent cholecystitis was lower in the EUS-guided drainage group (2.6% vs 18.8%, respectively; P = .023) on univariate analysis but only trended to significance in a multiple regression model. Duration of follow-up, reintervention rates, hospital length of stay, and overall adverse event rates were similar between groups. CONCLUSIONS: EUS-guided GB drainage results in a higher clinical success rate compared with transpapillary drainage and may be associated with a lower recurrence rate of cholecystitis. However, transpapillary drainage should be considered as the first-line treatment for patients who are surgical candidates but require temporizing measures or require an ERCP for alternative reasons.
引用
- Higa JT, Sahar N, Kozarek RA, et al. EUS-guided gallbladder drainage with a lumen-apposing metal stent versus endoscopic transpapillary gallbladder drainage for the treatment of acute cholecystitis (with videos). Gastrointest Endosc. 2019. PMID: 31054909. doi:10.1016/j.gie.2019.04.238
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。